A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2004
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	US20040236135 Preparation and use of alpha-keto phosphonates
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236112 Hepatitis C Virus (HCV); antiproliferative agents; replication-defective
11/25/2004	US20040236105 Triazole derivatives useful in therapy
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236098 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235950 Administering, topically or systemically, an inhibitor of the matrix degrading enzymes and a cytokine inhibitor that alleviates inflammation and also alleviate neutrophil infiltration
11/25/2004	US20040235944 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
11/25/2004	US20040235938 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235927 Synthesis and antimicrobial activity of novel dicationic "reversed amidines"
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235917 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
11/25/2004	US20040235916 Thiazolyl amides and their use as antiviral drugs
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004	US20040235900 Antimicrobial oxazolifinones with improved pharmacokinetic profile and safety advantages
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235869 For therapy of subject infected with a retrovirus
11/25/2004	US20040235868 Purine derivatives having, in particular, anti-proliferative properties and their biological uses
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235817 Crystalline forms of ertapenem sodium
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235798 Identifying a small organic molecule having a core structure, the small organic molecule having a cytotoxic antifungal activity; andpreparing a compound comprising the core structure of the identified cytotoxic antifungal agent
11/25/2004	US20040235789 Isomaltooligosaccharides from Leuconostoc as neutraceuticals
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235784 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents
11/25/2004	US20040235782 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/25/2004	US20040235781 Pharmaceutical composition of antiviral agents
11/25/2004	US20040235780 Pharmaceutical composition of antiviral agents
11/25/2004	US20040235779 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235761 Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
11/25/2004	US20040235760 5-O-mycaminosyltylonide derivatives
11/25/2004	US20040235759 Increasing acute or chronic injection-site toleration in mammals by administering single dose descladinose azalide derivative mixture
11/25/2004	US20040235745 Basic polypeptide against Grampositive and Gramnegative bacteria; noncytoxic
11/25/2004	US20040235741 Human papilloma virus treatment
11/25/2004	US20040235726 Glucagon-like peptides (glp-1) and treatment of respiratory distress
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040235156 Therapeutic mixture comprising interferons and chimeric immunoglobulins for use in activation of immune response and treatment, diagnosis and prevention of cancer; immunotherapy; tissue targeted therapy
11/25/2004	US20040235134 Newcastle disease virus infectious clones, vaccines and new diagnostic assays
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040234951 Chimeric chains that coding for proteins that induce effects directed against viruses
11/25/2004	US20040234950 Method for virus propagation
11/25/2004	US20040234601 Absorption in upper part oof digestive system; oral administering
11/25/2004	US20040234572 Preparation of sustained release pharmaceutical composition
11/25/2004	US20040234553 Cold-adapted equine influenza viruses
11/25/2004	US20040234552 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine
11/25/2004	US20040234550 Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
11/25/2004	US20040234545 Aids and leukemia therapy; enhancing immunology response; promote secretion of peptide such as defensin
11/25/2004	US20040234543 Hepatitis virus
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234533 Antigenic compositions
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234503 Materials and methods relating to improved vaccinations strategies
11/25/2004	US20040234501 administering lamivudine; suppression reproduction of hepatitis virus; interferons
11/25/2004	US20040234493 Quaternary polyamidoamines, the production thereof, corresponding agents and the use thereof
11/25/2004	US20040234474 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery
11/25/2004	US20040232205 Lantibiotic
11/25/2004	DE4307422B4 Verfahren zur Herstellung von Clavulansäuresalzen Process for the preparation of salts of clavulanic acid
11/25/2004	CA2566874A1 Targeted delivery of anti-viral compounds through hemoglobin bioconjugation
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525539A1 Treatment kit to assist in antibiotic therapy in intracellular infectious diseases
11/25/2004	CA2525522A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	CA2525370A1 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	CA2525143A1 New 3-decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
11/25/2004	CA2524847A1 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases
11/25/2004	CA2522614A1 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
11/24/2004	EP1479773A1 Mite galectin
11/24/2004	EP1479695A1 Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1479691A1 Long lasting fusion peptide inhibitors for HIV infection
11/24/2004	EP1479687A1 Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these
11/24/2004	EP1479681A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE
11/24/2004	EP1479394A1 The use of epidermal growth factor (EGF) for increasing weight gain in an animal
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478770A2 Screening method for orthopoxvirus antivirals
11/24/2004	EP1478766A2 Methods for determining the influence of protein binding on antiretroviral activity
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004	EP1478738A1 Anti-ccr5 antibody
11/24/2004	EP1478731A1 Phenalenone derivatives, method for the production thereof and use of the same
11/24/2004	EP1478730A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 1798